Ms. McCourt joined Medivation as chief operating officer in February 2016. She has more than two decades of wide-ranging executive management leadership experience at some of the world's most innovative biopharmaceutical companies. Previously she served as a vice president in U.S. commercial operations for Amgen Inc., one of the world's leading independent biotechnology companies, where she was part of the team that drove the Launch Readiness for multiple assets and led the Organized Customer Team. She also served as the vice president/general manager of the Bone Health & Primary Care Business Unit. Previously, she was the chief operating officer for AstraZeneca U.S. with leadership and P & L accountability for AstraZeneca's largest market with $13 billion in sales. Her responsibilities included oversight and direct report of all U.S. commercial functions, including medical affairs, business development, finance, human resources, legal, operations, payer-government and sales and marketing. During her 12-year tenure at AstraZeneca, Ms. McCourt was President & CEO of AstraZeneca Canada Inc. and also held the following roles in AstraZeneca Pharmaceuticals LP: Vice President US Business Development, Strategy & Launch; Vice President of Business Units; and Vice President Managed Markets, Government & Policy. She holds a B.S. degree in Biology from Lafayette College

 Pharmaceuticals